AVLN Stock: Price, Earnings History and SEC Filings
Avalyn Pharma Inc. (AVLN) last traded at $25.63, down 0.31% on the latest session and down 10.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.98 against an analyst estimate of $-1.03, a beat of 4.9%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AVLN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 12, 2026 | $-0.98 | $-1.03 | +4.85% |
| Mar 2026 | Jun 3, 2026 | $-21.83 | $-16.38 | -33.27% |
AVLN beat the analyst EPS estimate in 1 of its last 2 reported quarters. Source: Nasdaq.
Latest SEC filings for AVLN
- 8-K · Sep 16, 2026Officer or director change
- 10-Q · Aug 12, 2026
- 8-K · Aug 12, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 1, 2026Material agreement, Financial statements and exhibits
- 8-K · Jun 17, 2026Regulation FD disclosure
- 10-Q · Jun 3, 2026
- 8-K · Jun 3, 2026Results of operations, Financial statements and exhibits
- 8-K · May 1, 2026Bylaw change, Financial statements and exhibits
- 424B4 · Apr 30, 2026
- S-1 · Apr 8, 2026
Insider filing activity
AVLN insiders filed 1 Form 4 report in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
AVLN news
No recent headlines found. The live terminal has the full news feed.
About Avalyn Pharma Inc.
Avalyn Pharma Inc. (AVLN) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in DE. Its fiscal year ends in December.